SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-029031
Filing Date
2023-05-12
Accepted
2023-05-12 16:16:10
Documents
2
Period of Report
2023-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4265
2 POA DOCUMENT poa.txt EX-24 3148
  Complete submission text file 0001209191-23-029031.txt   8811
Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address
Morrison Scott W (Reporting) CIK: 0001662426 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40407 | Film No.: 23915941

Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Issuer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations